Home › Forums › Clinical Practice › prescribing GLP-1s in psychiatry › Reply To: prescribing GLP-1s in psychiatry
Emily – wow. I think your concerns are very valid.
I did not attend psychiatry residency, so I have a lot of questions. Are psychiatrists prescribing statin therapy for people with mortality risk of cardiovascular events, or blood pressure, or diabetes? It seems out of scope to me to be prescribing GLP-1 medications for weight loss in a psychiatry practice, given that the medications aren’t currently FDA-approved for psychiatric conditions (I know there has been interest for research on their use for alcohol use disorder and binge eating disorder, but I don’t think that data currently exists), and their impact is far beyond psychiatric outcomes.
Also, is there data that GLP-1s “bend the mortality curve”? If there is, I might be missing it.
But I’d be open to hearing what others think.